“Starting today, Merck & Co., Inc., will begin disclosing grants provided by its Global Human Health Division to U.S. organizations in support of independent accredited educational programs for health care professionals, the portion of dues that major U.S.-based trade associations report to the company as being used for advocacy and/or political activities in the United States, and the registration status by country for two of the company's newest vaccines and all of its HIV medicines as part of its increased commitment to transparency,” according to a Merck press statement.

“Merck will begin disclosing the information in its 2006 – 2007 global corporate responsibility (CR) report, which it published today. The report, includes more than 65 key performance indicators on environmental, social and governance issues of greatest significance to Merck and its stakeholders. It focuses on five key areas: Researching and developing new medicines and vaccines that address unmet needs; improving access to medicines, vaccines and health care; ensuring confidence in the safety and quality of Merck products; conducting business ethically and transparently; managing Merck’s environmental footprint “